Abstract
Introduction: Post-percutaneous coronary interv2ntion (PCI) assessment of ST-segment resolution (STR) serves as a vital indicator of perfusion at heart micro vessels in patients with ST-segment elevation myocardial infarction (STEMI). NT-pro BNP emerges as a significant biomarker, aiding in risk stratification and prognostication in acute coronary syndrome. The aim of the study objective was to find out association between on admission N-terminal pro-B-type natriuretic peptide (NT-pro BNP) and ST-segment resolution and predicting about reperfusion before primary PCI.
Methods: This cross-sectional analytical study was carried out at national Heart Foundation Hospital & Research Institute (NHFH&RI) for one year from May 2023 to April 2024 involved 104 patients with STEMI who met the inclusion and exclusion criteria. A digital 12-lead ECG was recorded at admission and 60 minutes after primary PCI and blood samples were collected for NT-pro BNP. ST segment resolution ≥50% was considered as successful reperfusion and categorized as Group I, whereas STR<50% was considered failed reperfusion and categorized as Group II.
Results: Result revealed that maximum patient was in 51-60years age group (38.4%) and male predominant (86.5%). Diabetes mellitus (68.96%), hypertension (86.20%) and dyslipidemia (86.20%) were more in Group II. The mean (±SEM) NT-pro BNP level In Group I and group II was 385±53.47pg/ml and 6727±1286.39pg/ml respectively. Notably, NT-pro-BNP ≥688pg/ml showed highest Youden Index with sensitivity of 86.2%, specificity of 85.3%, positive predictive value (PPV) of 69.44%, negative predictive value (NPV) of 94.12% and accuracy of 85.58% to predict failed ST resolution.
Conclusions: NT-pro BNP level on admission is an important biomarker to predict ST resolution after Primary PCI.
Full text
Read the article in your browser with search, text selection and highlighting, open it full screen, or download the PDF.